PRECISION OPTICS CORPORATION, INC. Increase (Decrease) in Deferred Revenue
PRECISION OPTICS CORPORATION, INC. (POCI) reported Increase (Decrease) in Deferred Revenue of $347.27 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-05-13
- PRECISION OPTICS CORPORATION, INC. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $347.27K, a 13.77% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was $269.33K, a 25.54% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $1.13M, a 139.80% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was $225.76K, a 63.31% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. increase (decrease) in deferred revenue for fiscal 2025 was $1.36M, a 29.92% decline from fiscal 2024.
- PRECISION OPTICS CORPORATION, INC. increase (decrease) in deferred revenue for fiscal 2024 was $1.95M, a 23.51% decline from fiscal 2023.
- PRECISION OPTICS CORPORATION, INC. increase (decrease) in deferred revenue for fiscal 2023 was $2.55M, a 32.67% decline from fiscal 2022.
- PRECISION OPTICS CORPORATION, INC. increase (decrease) in deferred revenue for fiscal 2022 was $3.78M, a 185.95% increase from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $347.27K 10-Q · filed 2026-05-13 | $616.61K derived: sum of 2 quarters · filed 2026-05-13 | $1.75M 10-Q · filed 2026-05-13 | $1.97M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-12-31 | $269.33K 10-Q · filed 2026-02-17 | $1.40M 10-Q · filed 2026-02-17 | $1.63M derived: sum of 3 quarters · filed 2026-02-17 | $1.93M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-09-30 | $1.13M 10-Q · filed 2025-11-13 | $1.36M derived: sum of 2 quarters · filed 2025-11-13 | $1.66M derived: sum of 3 quarters · filed 2026-05-13 | $2.02M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-06-30 | $225.76K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $531.00K derived: sum of 2 quarters · filed 2026-05-13 | $892.72K derived: sum of 3 quarters · filed 2026-05-13 | $1.36M 10-K · filed 2025-09-29 | |
| 2025-03-31 | $305.25K 10-Q · filed 2026-05-13 | $666.96K derived: sum of 2 quarters · filed 2026-05-13 | $1.14M 10-Q · filed 2026-05-13 | $1.75M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $361.71K 10-Q · filed 2026-02-17 | $833.33K 10-Q · filed 2026-02-17 | $1.45M derived: sum of 3 quarters · filed 2026-02-17 | $2.07M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | $471.62K 10-Q · filed 2025-11-13 | $1.09M derived: sum of 2 quarters · filed 2025-11-13 | $1.71M derived: sum of 3 quarters · filed 2025-11-13 | $1.99M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $615.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $1.24M derived: sum of 2 quarters · filed 2025-09-29 | $1.51M derived: sum of 3 quarters · filed 2025-09-29 | $1.95M 10-K · filed 2025-09-29 | |
| 2024-03-31 | $625.91K 10-Q · filed 2025-05-15 | $898.49K derived: sum of 2 quarters · filed 2025-05-15 | $1.33M 10-Q · filed 2025-05-15 | $1.96M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $272.57K 10-Q · filed 2025-02-13 | $705.69K 10-Q · filed 2025-02-13 | $1.33M derived: sum of 3 quarters · filed 2025-02-13 | $2.35M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-09-30 | $433.12K 10-Q · filed 2024-11-14 | $1.06M derived: sum of 2 quarters · filed 2024-11-14 | $2.08M derived: sum of 3 quarters · filed 2024-11-14 | $2.52M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $627.56K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $1.65M derived: sum of 2 quarters · filed 2024-09-30 | $2.09M derived: sum of 3 quarters · filed 2024-09-30 | $2.55M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $1.02M 10-Q · filed 2024-05-15 | $1.46M derived: sum of 2 quarters · filed 2024-05-15 | $1.92M 10-Q · filed 2024-05-15 | $1.92M 10-Q · filed 2023-05-15 | $4.31M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $441.49K 10-Q · filed 2024-02-14 | $897.11K 10-Q · filed 2024-02-14 | $3.29M derived: sum of 3 quarters · filed 2024-02-14 | $4.06M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $455.61K 10-Q · filed 2023-11-14 | $2.85M derived: sum of 2 quarters · filed 2023-11-14 | $3.62M derived: sum of 3 quarters · filed 2023-11-14 | $4.16M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $3.17M derived: sum of 2 quarters · filed 2023-09-28 | $3.70M derived: sum of 3 quarters · filed 2023-09-28 | $3.78M 10-K · filed 2023-09-28 | |
| 2022-03-31 | $774.32K 10-Q · filed 2023-05-15 | $1.31M derived: sum of 2 quarters · filed 2023-05-15 | $1.39M 10-Q · filed 2023-05-15 | $2.22M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $537.14K 10-Q · filed 2023-02-14 | $742.53K 10-Q · filed 2023-02-14 | $1.45M derived: sum of 3 quarters · filed 2023-02-14 | $1.89M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-09-30 | $205.39K 10-Q · filed 2022-11-14 | $913.01K derived: sum of 2 quarters · filed 2022-11-14 | $1.36M derived: sum of 3 quarters · filed 2022-11-14 | $1.48M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $707.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $1.15M derived: sum of 2 quarters · filed 2022-09-27 | $1.28M derived: sum of 3 quarters · filed 2022-09-27 | $1.32M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $442.68K 10-Q · filed 2022-05-16 | $570.25K derived: sum of 2 quarters · filed 2022-05-16 | $614.38K 10-Q · filed 2022-05-16 | $833.80K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $127.57K 10-Q · filed 2022-02-14 | $171.70K 10-Q · filed 2022-02-14 | $391.12K derived: sum of 3 quarters · filed 2022-02-14 | $433.00K derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-09-30 | $44.13K 10-Q · filed 2021-11-15 | $263.55K derived: sum of 2 quarters · filed 2021-11-15 | $305.43K derived: sum of 3 quarters · filed 2021-11-15 | $402.57K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $219.42K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $261.30K derived: sum of 2 quarters · filed 2021-09-28 | $358.44K derived: sum of 3 quarters · filed 2021-09-28 | $554.31K 10-K · filed 2021-09-28 | |
| 2020-03-31 | $41.87K 10-Q · filed 2021-05-13 | $139.02K derived: sum of 2 quarters · filed 2021-05-13 | $334.89K 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | $97.14K 10-Q · filed 2021-02-16 | $293.02K 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | $280.10K 10-Q · filed 2020-11-12 | ||||
| 2019-03-31 | $61.93K 10-Q · filed 2020-05-14 | $61.93K derived: sum of 2 quarters · filed 2020-05-14 | $81.68K 10-Q · filed 2020-05-14 | ||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-13 | $24.30K 10-Q · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |